TES Pharma

Perugia, Italy

TES Pharma is a research-based biopharmaceutical company.

$5.2M raised

Dec 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TES Pharma raised?

TES Pharma has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are TES Pharma's investors?

TES Pharma's investors include Indaco Venture Partners, XGEN Venture, Foro delle Arti.

Where is TES Pharma headquartered?

TES Pharma is headquartered in Perugia, Italy.

What does TES Pharma do?

TES Pharma is a research-based biopharmaceutical company.

What stage is TES Pharma at?

TES Pharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2024.

MLA

"TES Pharma — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/tes-pharma. Accessed July 2, 2026.

APA

VCBacked. (2024). TES Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tes-pharma

Wikipedia (cite web)

{{cite web |title=TES Pharma — Funding & Investors |url=https://www.vcbacked.co/company/tes-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2024.